Update of a phase I/II trial of carboplatin/gemcitabine plus escalating doses of celecoxib for first-line treatment of stage IIIB/IV non-small cell lung cancer (NSCLC)
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: J. D. Burton, E. Badine, D. El-Sayah, E. Dib, F. Forte, T. Terjanian, M. Odaimi, M. Vesoniaraki, P. Friscia, J. Lowry
Institution: Staten Island University Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2605100630